• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Double blind study using amantadine hydrochloride in the therapy of Parkinson's disease.

作者信息

Silver D E, Sahs A L

出版信息

Trans Am Neurol Assoc. 1971;96:307-8.

PMID:4945919
Abstract
摘要

相似文献

1
Double blind study using amantadine hydrochloride in the therapy of Parkinson's disease.
Trans Am Neurol Assoc. 1971;96:307-8.
2
Controlled trial of amantadine hydrochloride in Parkinson's disease.
N Z Med J. 1971 May;73(468):263-7.
3
Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.
Trans Am Neurol Assoc. 1969;94:85-90.
4
L-dopa and amantadine hydrochloride in Parkinson's disease.
Int Z Klin Pharmakol Ther Toxikol. 1971 Apr;4(3):356-60.
5
Experiences with amantadine hydrochloride in Parkinson's disease.盐酸金刚烷胺治疗帕金森病的经验
Practitioner. 1971 Nov;207(241):679-80.
6
[Treatment of Parkinson's disease with amantadine].
Therapeutique. 1972 Nov;48(9):555-60.
7
[Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
HNO. 1970 Nov;18(11):390-7.
8
[Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
Wien Med Wochenschr. 1971 May 8;121(19):390-7.
9
[Amantadine treatment in Parkinson's disease].[金刚烷胺治疗帕金森病]
Nord Med. 1970 Nov 26;84(48):1518-20.
10
A controlled study of the clinical effects of amantadine hydrochloride (Symmetrel).
Curr Ther Res Clin Exp. 1973 Aug;15(8):552-8.

引用本文的文献

1
Progressive supranuclear palsy: Advances in diagnosis and management.进行性核上性麻痹：诊断和治疗的进展。
Parkinsonism Relat Disord. 2020 Apr;73:105-116. doi: 10.1016/j.parkreldis.2020.04.014. Epub 2020 May 25.
2
Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3).ADDS-5102（金刚烷胺）控释胶囊治疗帕金森病左旋多巴诱导运动障碍的随机、安慰剂对照试验（EASE LID 3）。
Mov Disord. 2017 Dec;32(12):1701-1709. doi: 10.1002/mds.27131. Epub 2017 Aug 21.
3
ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical Trial.
用于帕金森病左旋多巴诱导异动症的ADS-5102（金刚烷胺）缓释胶囊（EASE LID研究）：一项随机临床试验。
JAMA Neurol. 2017 Aug 1;74(8):941-949. doi: 10.1001/jamaneurol.2017.0943.
4
Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study).金刚烷胺缓释剂治疗帕金森病左旋多巴诱导的异动症（EASED研究）。
Mov Disord. 2015 May;30(6):788-95. doi: 10.1002/mds.26159. Epub 2015 Feb 4.
5
NMDA receptors in clinical neurology: excitatory times ahead.临床神经学中的NMDA受体：兴奋的未来
Lancet Neurol. 2008 Aug;7(8):742-55. doi: 10.1016/S1474-4422(08)70165-0.
6
Amantadine in Parkinson's disease.金刚烷胺在帕金森病中的应用。
Cochrane Database Syst Rev. 2003;2003(1):CD003468. doi: 10.1002/14651858.CD003468.